In contrast, increased expression of ATG3 was significantly associated with a lower body mass index (BMI) in the entire cohort of NPC patients (P = 0.046), although it did not correlate with other patient characteristics. This evidence concerns the gene ATG3 and nasopharyngeal carcinoma.